What is LOPJLB’s current signal on SABS?

LOPJLB’s latest quantitative signal on SAB Biotherapeutics, Inc. (SABS) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is SABS in?

SAB Biotherapeutics, Inc. (SABS) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does SAB Biotherapeutics, Inc. (SABS) do?

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabete…

Where is SAB Biotherapeutics, Inc. based / listed?

SAB Biotherapeutics, Inc. is based in US, listed on NASDAQ.

SAB Biotherapeutics, Inc. (SABS)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.89+0.35%Close

SELLCRISIS · day 10

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $28M
Beta: 0.58
P/E (TTM): 0.82

Short % float: 45.51%
Days to cover: 13.4
SI change: -12.6%

1W: -5.56%
1M: -16.95%

vs SPY 1W: -7.11%
vs SPY 1M: -18.72%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Prediction markets

Company news